## **Core Concept**
The question tests knowledge of prenatal screening markers for neural tube defects (NTDs). Neural tube defects, such as spina bifida and anencephaly, are birth defects of the brain or spine. Screening for these conditions involves various biochemical markers.

## **Why the Correct Answer is Right**
Alpha-fetoprotein (AFP) is a protein produced by the yolk sac and then by the fetal liver during pregnancy. Elevated levels of AFP in maternal serum or amniotic fluid are associated with an increased risk of neural tube defects. This is because in NTDs, the neural tube fails to close properly, leading to the leakage of AFP into the amniotic fluid, which can then be detected in maternal serum.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain substances can be markers for various conditions, without specific identification, it's hard to directly refute. However, commonly, markers like estriol, inhibin A, and hCG are more closely associated with Down syndrome screening rather than specifically with NTDs.
- **Option B:** This option is not specified, but generally, other markers like inhibin A, estriol, and hCG are used in prenatal screening for different conditions.
- **Option D:** Without specific details on the marker, it's challenging to directly address. However, it's known that not all listed options (A, B, D) are primarily recognized as markers for neural tube defects.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **AFP levels are used for screening neural tube defects**. Specifically, maternal serum AFP (MSAFP) screening between 16 and 20 weeks of gestation can help identify pregnancies at increased risk for NTDs. However, it's crucial to follow up with more definitive diagnostic testing, such as amniocentesis and ultrasound, for confirmation.

## **Correct Answer:** . Alpha-fetoprotein (AFP)